Example: Heart Attack
Clinical Trials on Neoplasms, Plasma Cell
Total 3129 results
-
NCT04271644RecruitingConditions: Multiple Myeloma; Neoplasm, Plasma Cell; Multiple Myeloma in Relapse
-
NCT04322292RecruitingConditions: Multiple Myeloma
-
NCT04295018RecruitingConditions: Multiple Myeloma
-
NCT04272151RecruitingConditions: Multiple Myeloma; Multiple Myeloma in Relapse; Neoplasm, Plasma Cell
-
NCT04537442RecruitingConditions: Multiple Myeloma
-
NCT04024384WithdrawnConditions: Multiple Myeloma
-
NCT03782064Active, not recruitingConditions: Multiple Myeloma
-
NCT03689595RecruitingConditions: Multiple Myeloma
-
NCT04318327RecruitingConditions: Multiple Myeloma
-
NCT03506386CompletedConditions: Multiple Myeloma
-
NCT03670173RecruitingConditions: Multiple Myeloma
-
NCT04151615RecruitingConditions: Multiple Myeloma
-
NCT03757221RecruitingConditions: Multiple Myeloma
-
NCT03006315Active, not recruitingConditions: Multiple Myeloma; Myeloma
-
NCT03127761RecruitingConditions: Multiple Myeloma
-
NCT03657420WithdrawnConditions: Multiple Myeloma
-
NCT04119336Active, not recruitingConditions: Relapsed Multiple Myeloma; Refractory Multiple Myeloma
-
NCT03091257RecruitingA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaConditions: Multiple Myeloma
-
NCT02095379CompletedConditions: Multiple Myeloma
-
NCT03992170RecruitingConditions: Myeloma Multiple
-
NCT03713294RecruitingConditions: Refractory Plasma Cell Myeloma
-
NCT03227432WithdrawnConditions: Multiple Myeloma
-
NCT04151667RecruitingConditions: Multiple Myeloma
-
NCT04212858Not yet recruitingConditions: Multiple Myeloma
-
NCT02477215CompletedConditions: Multiple Myeloma